BENJAMIN REESE: Open Payments
NPI 1295167989 · HENDERSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,359 in 86 payments from 15 companies in 2025. Trend: 2023 $1,494 · 2024 $1,800 · 2025 $1,359
Food & beverage: $1,359
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $346 |
| PFIZER INC. | 17 | $262 |
| Amgen Inc. | 11 | $155 |
| Novo Nordisk Inc | 9 | $135 |
| Lilly USA, LLC | 3 | $59 |
| ACADIA Pharmaceuticals Inc | 2 | $53 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Lundbeck LLC | 3 | $47 |
Products named: VRAYLAR, NURTEC ODT, OTEZLA, QULIPTA, Ozempic, REXULTI, ELIQUIS, DAYBUE.
Industry payments across TN — which companies pay providers there.
